Investor List:

Top Medical Devices Series B Investors in New York City (55)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Thilo Semmelbauer, Managing Director at Insight Partners
Thilo Semmelbauer
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Steve Kraus, Partner at Bessemer Venture Partners
Steve Kraus
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in Boston / New England, Investors in New York (NY), Investors in Boston (MA)
Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists)
Photo of Alex Glassman, Vice President at Insight Partners
Alex Glassman
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in New York City (Other Lists), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed)
Photo of Connor Guess, Vice President at Insight Partners
Connor Guess
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Diyong Xu, Principal at OrbiMed
Diyong Xu
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Series B), Investors in New York City (Other Lists), Investors in FinTech (Seed)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Medical Devices (Series B), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in Medical Devices (Series B), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Robotics (Series A), Investors in Washington, D.C. (Other Lists), Investors in BioTech (Series B), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists)
Photo of Cris De Luca, Partner at Sanofi Ventures
Cris De Luca
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Israel, Investors in New York (NY), Investors in Europe, Investors in San Francisco (CA), Investors in Cambridge (MA)
Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AR/VR (Series B), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in AR/VR (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in IoT (Series B), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in AR/VR (Series B), Investors in Diagnostics (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in AR/VR (Series A), Investors in AR/VR (Series B), Investors in Pharmaceuticals (Series A), Investors in IoT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series B), Investors in Medical Devices (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in IoT (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in IoT (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in AR/VR (Series A), Investors in Health IT (Series A), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in AI (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Medical Devices (Series A), Investors in AI (Series B), Investors in IoT (Series A), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in IoT (Series B), Investors in AR/VR (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Digital Health (Series B), Investors in Israel (Other Lists), Investors in AI (Series B), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in AI (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health IT (Series A), Investors in New York City (Other Lists), Investors in AI (Series A), Investors in San Francisco Bay Area (Other Lists)